PRAX 330

Drug Profile

PRAX 330

Alternative Names: GS967; PRAX-330

Latest Information Update: 20 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Praxis Precision Medicines
  • Developer Northwestern University Feinberg School of Medicine
  • Class Antiepileptic drugs; Neuroprotectants; Pyridines; Small molecules; Triazoles
  • Mechanism of Action Nav1.6 voltage-gated sodium channel inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Epilepsy

Most Recent Events

  • 20 Nov 2017 Chemical structure information added
  • 03 Nov 2017 Preclinical trials in Epilepsy in USA (unspecified route) prior to 03/11/2017
  • 03 Nov 2017 Pharmacodynamics data from a preclinical trial in Epilepsy released by Northwestern University Feinberg School of Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top